Advancis Advances on Antibiotic News

Shares zoomed Tuesday after the the FDA agreed to consider the 's new drug application for its version of amoxicillin

The roller-coaster price action in shares of Advancis Pharmaceutical (AVNC) illustrates many of the perils of being a small drug development company.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.